Universal Medicare Pvt. Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Universal Medicare Pvt. Ltd.
Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal
Lilly partners with Kumquat to discover small molecule IO drug. Kite, Appia Bio collaborate on allogeneic cell therapies. AstraZeneca and Regeneron pursue novel metabolic therapies targeting GPR75. Lexeo and Stelios merge to focus on gene therapies for rare cardiovascular indications.
Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?
As emerging markets represent 32% of Sanofi
’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?
Emerging Markets At Stake As Viehbacher Departs Sanofi?
As emerging markets represent 32% of Sanofi’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?
In Challenging Times, Sanofi’s Viehbacher Explores New Pricing Models In Emerging Markets
In a rare spotlight opportunity, Sanofi CEO Christopher Viehbacher shares his views on emerging markets during a visit to Mumbai.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice